This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weiss, D. J. Articles by Mccullough, B. Search for Related Content PubMed PubMed Citation Articles by Weiss, D. J. Articles by Mccullough, B. Social Bookmarking                         What's this?

Platelet Kinetics in Dogs Treated with a Glycoprotein IIb/IIIa Peptide Antagonist

Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota 55108, weiss005{at}tc.umn.edu

Michael L. Mirsky

Department of Pathology, Rhone-Poulenc Rorer, 55 Arcola Road NW7, Collegeville, Pennsylvania 19426

Oral A. Evanson

Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota 55108

Jose Fagliari

Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota 55108

David Mcclenahan

Department of Veterinary PathoBiology, College of Veterinary Medicine, University of Minnesota, St. Paul, Minnesota 55108

Bruce Mccullough

Department of Pathology, Rhone-Poulenc Rorer, 55 Arcola Road NW7, Collegeville, Pennsylvania 19426

Platelet glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonists have been highly effective inhibitors of platelet aggregation in preclinical studies and in clinical trials. However, decreased platelet counts have been documented in preclinical studies and in some patients receiving GPIIb/IIIa antagonists. We evaluated changes in platelet kinetics and fate in dogs receiving the GPIIb/IIIa receptor antagonist RPR 109891 orally for 4 days. Dogs receiving RPR 109891 had a 22-52% decrease in platelet count with the nadirs at 3-5 days after initiation of treatment. Platelet survival time was reduced by 19%, and platelet half-life was reduced by 63%. Indium-111-labeled platelets were rapidly cleared from the blood within 1 hour after administration of RPR 109891 on treatment days 1 and 2. This clearing was associated with a sharp increase in radioactivity in spleen but not in liver or lung. Platelet clearance was markedly attenuated on treatment days 3 and 4. Platelet counts returned to baseline within 1 week after discontinuation of treatment. These data indicate that RPR 109891 causes rapid and selective sequestration of platelets in the spleen.

Key Words: Thrombocytopenia • RPR 109891 • platelet survival • scintigraphy

References

• Acuirre FV, Topol EJ, Ferguson JJ, Anderson K., Blankenship JC, Heuser RR, Sigmon K., Taylor M., Gottlieb R. (1995). Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. Circulation 91: 2882-2891.[Abstract/Free Full Text]
• Alexander JH, Harrington RA (1998). Recent antiplatelet drug trails in the acute coronary syndromes—Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT. Drug 56: 965-976.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Badenhorst PN, Lotter MG, Heyns AD, Van Reenan OR, Herbst C., Peters H., Kotze HF, Duyvene LJ, Minnaar PC (1982). The influence of the collection injury on the survival and distribution of indium-111-labeled canine platelets. Br J Haematol 52: 233-240.[Web of Science][Medline] [Order article via Infotrieve]
• Badenhorst PN, Peters H. (1986). Methodology of platelet imaging. In: Platelet Kinetics and Imaging, Heyns AP, Badenhorst PN, Lotter MG (eds). CRC Press, Boca Raton, FL, pp 159-168.
• Bednar B., Cummingham ME, McQueen CF (1997). Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartatic acid ligands in binding to glycoprotein IIb/IIIa on platelets. Cytometry 28: 58-65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Belcher EH, Berlin NI, Eernisse JG, Garby L., Heimpel H., Lea M., Lewis SM, McIntyre PA, Mollison PI, Murphy EA, Najean Y., Pettit JE, Szuri L. (1977). Recommended methods for radioisotope platelet survival studies. Blood 50: 1137-1144.[Free Full Text]
• Cannon C., McCabe CH, Borzak S. (1997). Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: Results of the TIMI 12 trial. Circulation 97: 340-349.[Web of Science]
• Collier BS (1998). Platelet IIb/IIIa antagonists: The first anti-integrin receptor therapeutics. J Clin Invest 99: 1467-1471.[Web of Science]
• Coller BS (1997). GPIIb/IIIa antagonists: Pathophysiology and therapeutic insights from c7E3 Fab. Thromb Haemostasis 23: 730-736.
• Collier BS, Folts JD, Scudder LE, Smith SR (1986). Antithrombotic effects of a monoclonal antibody to the platelet glycoprotein IIb/ IIIa receptor in an experimental animal model. Blood 68: 783-786.[Abstract/Free Full Text]
• Dore M., Hawkins HK, Entman Smith CW (1993). Production of a monoclonal antibody against canine GMP-140 (P-selectin) and studies of its vascular distribution in canine tissues. Vet Pathol 30: 213-222.[Abstract]
• Du X., Ginsberg MH (1997). Integrin IIβ3 and platelet function. Thromb Haemostasis 78: 96-100.[Web of Science][Medline] [Order article via Infotrieve]
• Du X., Plow EF, Frelinger AL, O'Toole TE, Loftus JC, Ginsberg MA (1991). Ligands "activate" integrin IIbβ3 (platelet GPIIb/IIIa). Cell 65: 409-416.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Escolar G., Leistikow E., White JG (1989). The fate of the open canalicular system in surface and suspension-activated platelets. Blood 74: 1983-1988.
• Foster RH, Wiseman LR (1998). ABCIXIMAB—A review of its use in ischemic heart disease. Drugs 56: 629-665.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Gawaz M., Ruf A., Neumann FJ, Pogatsa-Murry G., Dickfeld T., Zohlnhofer D., Schomig A. (1998). Effects of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Thromb Haemostasis 80: 994-1001.[Web of Science][Medline] [Order article via Infotrieve]
• Giugliano RP (1998). Drug-induced thrombocytopenia—Is it a serious concern for glycoprotein IIbIIIa receptor inhibitors. J Thromb Thrombolysis 5: 191-202.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Greenberg JP, Packham MA, Guccione MA, Guccione MA, Rand ML, Reimers HJ, Mustard JF (1979). Survival of rabbit platelets treated in vitro with chymotrypsin, plasmin, trypsin, or neuraminidase. Blood 53: 916-922.[Free Full Text]
• Gulba DC, Huber K., Moll S., Dietz R. (1998). Platelet inhibition-New agents, new strategies, new trails. Fibrinolysis Proteolysis 12: 13-23.[Web of Science]
• Hubert M., Kunicki TJ, Bihour C., Winckler J., Nurden AT (1996). Visualization of activation-dependent epitopes on glycoprotein IIb/ IIIa complexes of platelets stimulated by thrombin-immunogold staining of ultrathin sections. Semin Thromb Haemostasis 22: 279-288.[Web of Science][Medline] [Order article via Infotrieve]
• Hughes A., Tonks RS (1962). Intravascular platelet clumping in rabbits. J Pathol Bacteriol 84: 379-390.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Itoh H., Cicala C., Douglas GJ, Page CP ( 1997). Platelet accumulation induced by bacterial endotoxin in rats. Thromb Res 83: 405-419.[CrossRef][Web of Science]
• Kotze HF, van Wyk V., Badenhorst PN, Heyns du P., Roodt JP, Lotter MG (1993). Influence of platelet membrane sialic acid and platelet-associated IgG on aging and sequestration of blood platelets in baboons. Thromb Haemostasis 70: 676-680.[Web of Science][Medline] [Order article via Infotrieve]
• Kotze HF, Wessels P., Peters H. (1986). Kinetics, redistribution, and sites of sequestration of normal platelets. In: Platelet Kinetics and Imaging, Heyns AP, Badenhorst PN, Lotter MG (eds). CRC Press, Boca Raton, FL, pp 107-123.
• Kristensen AT, Weiss DJ, Klausner J. (1994). Detection of antiplatelet antibody in the dog: Comparison of microscopic and fluorescence-activated cell sorter detection methods. Am J Vet Res 55: 1111-1114.[Web of Science][Medline] [Order article via Infotrieve]
• Leistikow EA, Barnhart MI, Escolar G., White J. (1990). Receptor-ligand complexes are cleared to the open canalicular system of surface-activated platelets. Br J Haematol 74: 93-100.[Web of Science][Medline] [Order article via Infotrieve]
• Lotter MG (1986). Methodology of platelet imaging. In: Platelet Kinetics and Imaging, Heyns AP, Badenhorst PN, Lotter MG (eds). CRC Press, Boca Raton, FL, pp 35-72.
• Mak KH, Tan Ath, Chan C., Koh TH, Topol EJ (1998). The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine. Jpn Circ J 62: 233-243.[CrossRef][Medline] [Order article via Infotrieve]
• Packhan MA, Guccione MA, Kinlough-Rathbone RL, Mustard JF (1980). Platelet sialic acid and platelet survival after aggregation by ADP. Blood 56: 876-883.[Abstract/Free Full Text]
• Peter K., Schwarz M., Ylanne J., Kohler B., Moser M., Nordt T., Salbach P., Kubler W., Bode C. ( 1998). Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa ( 2bβ3) inhibitors. Blood 92: 3240-3249.[Abstract/Free Full Text]
• Phillips DR, Charo IF, Parise LV, Fitzgerald LA (1988). The platelet membrane glycoprotein IIb-IIIa complex. Blood 71: 831-843.[Free Full Text]
• Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson KJ, Goodal AH, Michelson AD, Nurden AT, Shankey TV (1998). European working group on clinical cell analysis: Consensus protocol for the flow cytometric characterization of platelet function. Thromb Haemostasis 79: 885-896.22.
• Shattil S., Cunningham M., Hoxie JA (1987). Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood 70: 307-315.[Abstract/Free Full Text]
• Shattil SJ, Kashiwagi H., Pampori N. (1998). Integrin signaling: The platelet paradigm. Blood 92: 2645-2657.
• Thakur ML, Walsh L., Joist JH (1976). Indium-111-labeled human platelets: Studies on preparation and evalution of in vitro and in vivo functions. Thromb Res 9: 345-359.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vorchheimer DA, Fluster V. (1998). Oral platelet glycoprotein IIb/ IIIa receptor antagonists: The present challenge is safety. Circulation 97: 312-321.[Free Full Text]
• Weiss DJ, Evanson OA, Wells RE (1997). Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function. Am J Vet Res 58: 457-460.[Web of Science][Medline] [Order article via Infotrieve]
• Weiss DJ, Geor RJ, Johnston G., Trent AM (1994). Microvascular thrombosis associated with onset of acute laminitis in ponies. Am J Vet Res 55: 606-612.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 28, No. 2, 310-316 (2000)
DOI: 10.1177/019262330002800211


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Weiss, D. J. Articles by Mccullough, B. Search for Related Content PubMed PubMed Citation Articles by Weiss, D. J. Articles by Mccullough, B. Social Bookmarking                         What's this?